PharmaBoardroom

Interview with Michael Flemming, Chief Executive Officer, Life…

Our international readers know about South Africa’s socio-economic relative achievements, considering the country joined the BRICS grouping last…

Interview with Selwyn Kahanovitz, CEO, Litha Healthcare Group…

Mr Kahanovitz, Focus Reports came to South Africa in 2005 to produce a similar report on the South African pharmaceutical industry. Could you come…

Interview with Timothy Kedijang, General Manager, Novo Nordisk…

The story of Novo Nordisk South Africa began in 1959 in Johannesburg. It was among the first affiliates outside of Denmark, with insulin and…

Interview with WonJung Choi, President, Dream CIS

South Korea has a much shorter history of clinical trials than many other advanced economies. In your view, what is the potential for South Korea's…

Interview with Zdeněk Zahradník, General Manager, Teva Czech…

Mr. Zahradnik, you have long been an active member of the Czech generic drug makers’ association CAFF (Czech Association of Pharmaceutical…

Interview with Richard de Chastelain, Country Division Head,…

Since we interviewed you in 2005, there have been many changes in the market, from consolidation, an increasing generic penetration, to new healthcare…

Interview with Hoon Han, President, Histostem

After spending a large part of your career as a university professor, what drove you to create your own company, Histostem, in 2000? In 1993, I…

Interview with Laura Engelbrecht Joubert, General Manager –…

Ms Joubert, could you start by telling our readers over the 16 months of heading the operations here, what have been the most challenging situations…

Stephen Saad, Group Chief Executive, Aspen

The line between research based pharmaceutical companies and generic companies is today less and less relevant, as we have seen in the past few years…